Self-monitoring treatment programme with oral vitamin K antagonists in paediatric patients

Self-monitoring treatment programme with oral vitamin K antagonists in paediatric patients

Bibliographic Details
Main Authors:	Rubén Berrueco, Cristina Benedicto, Anna Ruiz-Llobet, Susanna Gassiot, Albert Català
Format:	Article
Language:	Spanish
Published:	Elsevier 2018-12-01
Series:	Anales de Pediatría (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2341287918301753

Similar Items

Programa de autocontrol del tratamiento anticoagulante oral con antagonistas de la vitamina K en pacientes pediátricos
by: Rubén Berrueco, et al.
Published: (2018-12-01)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01)

Non-vitamin K antagonist oral anticoagulants for heart diseases
by: T B Kondratieva, et al.
Published: (2017-09-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
by: Michele Malagù, et al.
Published: (2023-03-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
by: Adel Khalifa Sultan Hamad
Published: (2022-01-01)

Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage
by: Szu-Ju Chen, et al.
Published: (2020-01-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

Non-vitamin K antagonist oral anticoagulants in adults with congenital heart disease
by: Ji-Eun Ban
Published: (2022-09-01)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
by: Giuseppe Santarpia, et al.
Published: (2015-01-01)

Non-vitamin K antagonist oral anticoagulation agents in patients with atrial fibrillation: Insights from Italian monitoring registries
by: P.P. Olimpieri, et al.
Published: (2020-02-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Controversies in the treatment of paediatric immune thrombocytopenia
by: Rubén Berrueco, et al.
Published: (2018-09-01)

Portable coagulometer for vitamin K-antagonist monitoring: the patients’ point of view
by: Barcellona D, et al.
Published: (2018-08-01)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
by: Fabrice F. Darche, et al.
Published: (2023-06-01)

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes
by: Andrea Rubboli
Published: (2013-12-01)

Anticoagulants in clinical practice. The place of vitamin K antagonists in combination with new oral anticoagulants
by: T. V. Vavilova
Published: (2015-12-01)

Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Ki Hong Lee, et al.
Published: (2023-09-01)

Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
by: Gencheva Dolina
Published: (2023-09-01)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
by: Kateryna Fedorov, et al.
Published: (2021-08-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
by: Wenhao Li, et al.
Published: (2022-09-01)

Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants
by: Patel R
Published: (2016-05-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
by: Hansa Iqbal, et al.
Published: (2020-10-01)

Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey
by: Cimminiello, C, et al.
Published: (2018)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
by: Sergey Nikolaevich Bel'diev, et al.
Published: (2017-11-01)

Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World Studies
by: Larisa Anghel, et al.
Published: (2020-05-01)

Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells
by: Sergey Nikolaevich Bel'diev, et al.
Published: (2017-11-01)

Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
by: Lei Huang, et al.
Published: (2022-10-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants
by: Jose Raul Valery, et al.
Published: (2022-08-01)

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
by: Waltraud Pfeilschifter, et al.
Published: (2022-05-01)

Non-vitamin K oral antagonist failure and tailored treatment in patients with atrial fibrillation and stroke
by: Hyung Jun Kim, et al.
Published: (2020-03-01)

Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey
by: Claudio Cimminiello, et al.
Published: (2018-08-01)

Efficacy and safety of novel oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolism
by: Maodi Xu, et al.
Published: (2018-09-01)

New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.
by: Annachiara Bellin, et al.
Published: (2019-01-01)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
by: Daniele Pastori, et al.
Published: (2018-04-01)

Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study
by: Lihong Tang, et al.
Published: (2020-06-01)

Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
by: Giovanni Luca Botto, et al.
Published: (2021-06-01)